• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

CIME 2024: Cochair Neda Shamie gives praise to conference sessions

News
Article

CIME Cochair Neda Shamie, MD, gives an overview of presentations on Demodex blepharitis, LASIK, retina sessions, and more at this year's conference.

Neda Shamie, MD, cochair of Controversies in Modern Eye Care (CIME), gives high praise to the sessions at this year's CIME conference, ranging from retinal topics, Demodex blepharitis, technological advancements, and more. She also details her and Arjan Hura's, MD, multiple presentations on LASIK, ICLs, IOLs, refractive surgery, and more.

Video Transcript

Editor’s note - The following transcript has been lightly edited for clarity.

Neda Shamie, MD:

Hi, everyone! My name is Neda Shamie. I'm a cornea, refractive, and cataract surgeon here in Los Angeles at the Maloney-Shamie Vision Institute. I'm one of the two program directors together with Dr. Arjan Hura of the Controversies in Modern Eye Care [conference] that's being held today in Los Angeles, actually at the Studio City Universal Studios Hilton.
It's been a wonderful, wonderful meeting thus far. We just had our morning session. We're breaking for lunch right now. This is our 18th annual meeting. The morning highlights Dr. Hura and I both presented together on refractive surgical options focusing on all of the different options available to patients who are seeking freedom from glasses and contact lenses if they have myopia. We talked about the benefits of LASIK, more advanced LASIK, and taking advantage of systems such as the iDesign refractive studio, which basically involves diagnostics that really assess more than 1200 spots of the cornea and the optical system for the most customized treatment profile for each patient.

Then we went on to talk about the EVO ICL as an alternative to corneal-based refractive procedures for those who are not candidates for LASIK or PRK, as well as those who are candidates but are seeking a more reversible procedure, one that doesn't change the anatomy of the eye.
And then we finished to talk about potentials for lenticular procedures such as SMILE, and more specifically SMILE Pro, which is on the very, very upcoming horizon that we at the Maloney-Shamie Vision Institute are excited to bring hopefully to our patients soon enough.

Then I was comoderating a session on Demodex blepharitis together with Drs Marc Bloomenstein and Jim Katz. It was a really 'mite-y' session talking about mites that can grow on our lashes and what kind of inflammation and problems they can cause of the ocular surface. More importantly, what treatments we have including the newest kind of the only treatment available in Xdemvy, which has been shown to be highly efficacious in treating Demodex blepharitis.

There's been a lot of other sessions. There was a fantastic session on retina talking about diabetic retinopathy that was beautifully run. It was one of the most well-done retina sessions I've ever been a part of it as an anterior segment surgeon. I payed attention quite a lot and learned a lot.

Another wonderful session about glaucoma that was really looking at cases and such. So far it's been a really rich morning and we're excited to move on to the afternoon and talk a little bit more about everything related to eye care.

Related Videos
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.